In spite of various headwinds, a strong uptick in surgical procedures and business activities in March was the slingshot effect needed to propel the US Orthobio Market into double-digit percentage growth for Q121.
In spite of the headwinds from a resurgence of COVID-19 cases in Q420 that spilled over to the early part of Q121 and winter storms of historical proportions in February, a strong uptick in elective surgical procedures in March was the slingshot effect the US Orthobio Market needed to propel it.
Among the many topics covered in detail in our comprehensive Q121 US Orthobio Market Recap* are: